Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 1997

View Archived Issues

New insights into glaucoma and implications for drug therapy

Rutaecarpine, a vasorelaxant component of an herbal drug

New treatment reported for diaper dermatitis

Englitazone mechanism of antidiabetic activity studied in vitro

Mechanism of topical absorption of antiandrogen drug investigated

Maxamine enters phase III for malignant melanoma

Interim U.S. phase III results reported for Gliatech's ADCON-L

ArQule and Wyeth-Ayerst enter into drug discovery collaboration

HIV protease inhibitor enters phase III pediatric trial

NeoTherapeutics begins U.S. clinical trials of AIT-082

Teva receives FDA approval for generic estazolam

The Population Council licenses two hormone replacement products to Sano

Update on CellPro's CEPRATE SC Stem Cell Concentration System

Allergan prepares compounds with retinoid-like activity

MMP inhibitors from Warner-Lambert

Celltech discloses potent and selective inhibitors of protein kinases

MS&D reveals agents for migraine

Chiroscience claims MMP/TNF inhibitors

Dual H1/NK1 antagonists from Hoechst Marion Roussel

Univ. of Pennsylvania team discovers new Alzheimer's lesion

ICRF-187 for preventing anthracycline cardiotoxicity in children

Immunomedics issued U.S. patent for cardiovascular diagnostic

Mibefradil more effective than extended-release diltiazem in hypertension

Efficacy of botulinum toxin type C in humans

Vitamin B12 depletion reported to induce apoptosis

Potent and selective M2 receptor antagonist discovered by Yamanouchi

Geron's telomerase technology covered under U.S. patent

Dainippon presents promising antisecretory agent

Bigmar submits ANDA for leucovorin

NIH researchers identify gene associated with Niemann-Pick type C

Eclipse submits PMA for Transmyocardial Revascularization procedure

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026